Editorial
Published on 13 Nov 2024
Editorial: Harnessing the potential of FLASH: questions we must address prior to effective clinical translation
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1515325
- 127 views
Type at least 3 characters
29,188 articles
Articles
Review
Published on 13 Nov 2024
Transcriptomic era of cancers in females: new epigenetic perspectives and therapeutic prospects
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2024.1464125
- 212 views
Systematic Review
Published on 13 Nov 2024
Tumor seeding across specialties: a systematic review
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2024.1464767
- 200 views
Review
Published on 13 Nov 2024
Current status of evaluation and treatment of early-stage remnant gastric cancer
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1457564
- 164 views
Correction
Accepted on 12 Nov 2024
Corrigendum: Global epidemiology and socioeconomic correlates of hypopharyngeal cancer in 2020 and its projection to 2040: findings from GLOBOCAN 2020
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2024.1520064
Original Research
Accepted on 12 Nov 2024
Identification of Intraoperative Hypoxemia and Hypoproteinemia as Prognostic Indicators in Anastomotic Leakage Post-Radical Gastrectomy: An 8-Year Multicenter Study Utilizing Machine Learning Techniques
in Surgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1471137
Review
Accepted on 12 Nov 2024
Regulation of ovarian cancer by protein post-translational modifications
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1437953
Mini Review
Accepted on 12 Nov 2024
Diagnosis Progress of Carcinoma of Unknown Primary (CUP)
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1510443
Original Research
Accepted on 12 Nov 2024
A real-world study: Third-line treatment options for metastatic colorectal cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1480704
Case Report
Accepted on 12 Nov 2024
Case Report: Prolonged Benefit of ESG401, a Trop2 Antibody-Drug Conjugate, in Endocrine-Refractory Hormone Receptor-Positive, HER-2 Negative Metastatic Breast Cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1444431
Original Research
Accepted on 12 Nov 2024
Combined systemic immune-inflammatory index and prognostic nutritional index predicts the efficacy and prognosis of ES-SCLC patients receiving PD-L1 inhibitors combined with first-line chemotherapy
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1485849
Original Research
Accepted on 12 Nov 2024
Development and validation of an individualized nomogram for predicting distant metastases in gastric cancer using a CT radiomicsclinical model
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1476340
Case Report
Accepted on 12 Nov 2024
Secondary Childhood Glaucoma in Neurofibromatosis Type 1: an unusual corneal leukoma case report
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1469969
Original Research
Accepted on 12 Nov 2024
Establishment and validation of a nomogram model for early diagnosis of gastric cancer: A large-scale cohort study
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1463480
Original Research
Accepted on 12 Nov 2024
Development of a new VMAT QA framework for Mobius3D using control-point specific EPID images
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1478118
Original Research
Published on 12 Nov 2024
An insight to PDAC tumor heterogeneity across pancreatic subregions using computed tomography images
in Cancer Imaging and Image-directed Interventions
Frontiers in Oncology
doi 10.3389/fonc.2024.1378691
- 303 views